However, its not commonly seen to directly cause sulfur burps
The FDA targets mass-marketed compounded GLP-1 drugs, warning of safety risks and deceptive ads as enforcement ramps up for weight-loss injectables
Although other conditions such as diabetes, hypertension or kidney disease might be concerns for some people, obesity and weight management are certainly just as valid health concerns. Researchers and clinicians continue to study how patients can best transition off GLP-1 medications while maintaining weight loss and improving overall health
TriHex 2.0-Advancing Skin Health Science and the TriHex Technology
In 17,604 adults with overweight or obesity and established cardiovascular disease but no diabetes, semaglutide 2.4 mg cut the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) by 20 percent over a mean follow-up of 39.8 months [9]